Pipeline Therapeutics Announces Participation at the 2023 Stifel CNS Days Conference
Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, announced today that management will participate in virtual one-on-one meetings with investors at the 2023 Stifel CNS Days Conference, being held in a …